A detailed history of Millrace Asset Group, Inc. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Millrace Asset Group, Inc. holds 166,042 shares of MDXG stock, worth $1.44 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
166,042
Previous 208,338 20.3%
Holding current value
$1.44 Million
Previous $1.44 Million 32.06%
% of portfolio
1.0%
Previous 1.4%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$5.65 - $7.76 $238,972 - $328,216
-42,296 Reduced 20.3%
166,042 $981,000
Q2 2024

Aug 12, 2024

BUY
$6.16 - $8.08 $42,904 - $56,277
6,965 Added 3.46%
208,338 $1.44 Million
Q1 2024

May 13, 2024

BUY
$7.61 - $8.63 $475,335 - $539,047
62,462 Added 44.97%
201,373 $1.55 Million
Q4 2023

Feb 12, 2024

SELL
$5.7 - $9.14 $258,768 - $414,937
-45,398 Reduced 24.63%
138,911 $1.22 Million
Q3 2023

Nov 13, 2023

BUY
$6.35 - $8.16 $176,911 - $227,337
27,860 Added 17.81%
184,309 $1.34 Million
Q2 2023

Aug 14, 2023

BUY
$3.14 - $6.61 $491,249 - $1.03 Million
156,449 New
156,449 $1.03 Million
Q1 2019

May 14, 2019

SELL
$1.84 - $3.74 $202,400 - $411,400
-110,000 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$1.15 - $6.45 $161,000 - $903,000
-140,000 Reduced 56.0%
110,000 $197,000
Q3 2018

Nov 13, 2018

BUY
$3.22 - $6.33 $404,032 - $794,263
125,476 Added 100.76%
250,000 $1.55 Million
Q2 2018

Aug 14, 2018

BUY
$5.39 - $8.96 $509,484 - $846,935
94,524 Added 315.08%
124,524 $796,000
Q1 2018

May 15, 2018

SELL
$6.69 - $17.96 $769,350 - $2.07 Million
-115,000 Reduced 79.31%
30,000 $209,000
Q4 2017

Feb 13, 2018

BUY
$10.87 - $13.9 $317,023 - $405,393
29,165 Added 25.18%
145,000 $1.83 Million
Q3 2017

Nov 13, 2017

SELL
$11.86 - $17.34 $128,479 - $187,844
-10,833 Reduced 8.55%
115,835 $1.38 Million
Q2 2017

Aug 11, 2017

BUY
N/A
126,668
126,668 $1.9 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $983M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Millrace Asset Group, Inc. Portfolio

Follow Millrace Asset Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Millrace Asset Group, Inc. with notifications on news.